EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patients

Kathryn Cassels iD, Raghad Almofeez, Jessica Roman, Hannah Steinberg, Ahana Byne, Amanda Haymond, Freddy Tinajeros, María Del Carmen Menduiña, Edith Málaga Machaca, Manuela Verástegui, José Luis Ramírez, Lance Liotta und 2 weitere

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Kathryn Cassels und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Antigens, Protozoan, Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Caused by the parasite Trypanosoma cruzi , Chagas disease affects an estimated 7 million people globally. Diagnosis of Chagas disease in infants is urgently needed, as early detection allows for more effective treatment and reduced mortality. However, current diagnostics are inappropriate for effective detection in infants due to differences in the mechanism of disease in infants and the infant immune system, as well as lack of diagnostic sensitivity and loss to follow up. Studying peripheral biomarkers in urine can leverage physiological concentration in the bladder to increase yield of proteins secreted by pathogen, infected cells, or antigen processed by immune cells residing in different body sites. Principal findings We analyzed the urine of a cohort of infants who were congenitally infected with Chagas disease, using a method including affinity enrichment, mass spectrometry, and bioinformatics analysis to characterize the T. cruzi secreted peptidome. We identified 198 peptides specific for T. cruzi and analyzed them in light of their potential for diagnostic utility. Our protocol revealed that peptides of the hyper-mutating mucin-associated surface protein and trans-sialidase protein families could be identified in patient urine and can serve as diagnostic markers of disease. We developed antibodies against conserved regions of each protein and validated that these antibodies could be used to differentiate the urine of Chagas disease patients (N = 16 cases) from healthy controls (N = 19). By utilizing affinity enrichment sample preprocessing and anti-trans-sialidase and anti-MASP antibodies in tandem, we differentiated cases from controls with 87.5% sensitivity and 94.7% specificity. Conclusions/Significance Our work suggests that it is possible to detect Trypanosoma cruzi infection directly from a noninvasively collected fluid such as urine. A direct test in urine with this success rate would be well suited for rapid diagnosis in low-resource areas. Further studies to validate this approach are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseTrypanosoma cruziAntigens, ProtozoanMass SpectrometryHumansInfantMaleFemaleAntibodies, ProtozoanBiomarkersInfant, NewbornNeuraminidaseGlycoproteins

Substanzen

Antigens, ProtozoanAntibodies, ProtozoanBiomarkerstrans-sialidaseNeuraminidaseGlycoproteins

Autor:innen und Institutionen

  • Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America.
  • Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois, United States of America.
  • Asociación Benéfica PRISMA, Lima, Peru.
  • Hospital Percy Boland Rodríguez, Ministerio de Salud Bolivia, Santa Cruz, Bolivia.
  • Infectious Diseases Research Laboratory, Department of Cellular and Molecular Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Biotechnology Center, Instituto de Estudios Avanzados, Caracas, Venezuela.

ORCID-Profile: Kathryn Cassels, Alessandra Luchini

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Cassels, K., Almofeez, R., Roman, J., Steinberg, H., Byne, A., Haymond, A., Tinajeros, F., Del Carmen Menduiña, M., Málaga Machaca, E., Verástegui, M., Ramírez, J. L., Liotta, L., Gilman, R. H., & Luchini, A. (2025). Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patients. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013082

Vancouver

Cassels K, Almofeez R, Roman J, Steinberg H, Byne A, Haymond A, et al. Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patients. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013082

BibTeX
@article{Cassels2025,
  author = {Cassels, Kathryn and Almofeez, Raghad and Roman, Jessica and Steinberg, Hannah and Byne, Ahana and Haymond, Amanda and Tinajeros, Freddy and Del Carmen Menduiña, María and Málaga Machaca, Edith and Verástegui, Manuela and Ramírez, José Luis and Liotta, Lance and Gilman, Robert H and Luchini, Alessandra},
  title = {Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patients},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013082}
}
Kostenlos starten →